Devana Solutions releases integrated CTMS solution

By Jenni Spinner contact

- Last updated on GMT

(NanoStockk/iStock via Getty Images Plus)
(NanoStockk/iStock via Getty Images Plus)

Related tags: Clinical trial management, Software, Research, data analysis, Data management

The company has announced its Ignite platform has been integrated with the Clinical Research IO clinical trial management software platform.

Devana Solutions has announced the completed integration of its Ignite platform with the Clinical Research IO (CRIO) clinical trial management platform. The measure is intended to help users increase efficiency, decrease trial cycle times, and speed the availability of new therapies to patients.

The Ignite platform is intended to automate trial workflows, capture important timing metrics, and provide robust reporting during study startup, screening and enrollment. The purpose of the CRIO integration is to further simplify trial processes and introduce more efficiency.

Devana Solutions director of strategic partnerships Emily Wike told Outsourcing-Pharma that pairing the Ignite and CRIO platforms helps trial teams realize a number of benefits around efficiency and effectiveness.

The combined technologies allow for a more streamlined approach to collecting data by eliminating the need to input critical study information into separate systems​,” she said. “Essentially, all data captured in either system is automatically transferred into and seamlessly displayed in the other platform​.”

CRIO co-founder Raymond Nomizu said his company is known for being an organization that “seamlessly addresses” any challenges that sites and sponsors encounter in their trials.

Our collaboration with another industry trail blazer, Devana, is a partnership that will further increase clinical trial efficiency​,” Nomizu said. “A data-driven approach enhances every site’s ability to make critical decisions and taking advantage of our technology allows sites to gather and analyze more data than ever before​.”

Wike said Devana plans to announce additional partnerships with Bio-Optronics and other organizations in the future, as well as reveal additional features to other platforms.

One such development is our new Site Capabilities feature that will soon be available to all of our Propel users​,” she said. “This new feature will allow users to centrally manage their sites’ capabilities and run queries to help match the best sites with the right protocols​.”

Related news

Related products

show more

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Introduction to eLAS®

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

Related suppliers

Follow us

Products

View more

Webinars